AI News NQ Analysis

NEC Group's blood testing service 'FonesVisuas' adopted by Royal Healthcare, a medical institution for high-net-worth individuals in Singapore

NQ Score 50/100

AI Summary (NQ-processed)

NEC's blood testing service adopted in Singapore.

AI analysis data is not yet available.

Frequently Asked Questions

Q: Which medical institution in Singapore has adopted the FonesVisuas blood testing service?
A: Royal Healthcare, a Singapore-based medical institution and a subsidiary of Sojitz Corporation, has adopted it.
Q: What does the FonesVisuas service analyze to visualize the current state of the body?
A: It analyzes proteins that change daily from a small amount of blood.
Q: Which diseases can the FonesVisuas service predict the risk of developing?
A: It predicts the risk of developing dementia, myocardial infarction, stroke, lung cancer, chronic kidney failure, and prostate cancer.
Q: Where is Royal Healthcare located, and what kind of services does it provide?
A: It is based in Novena, Singapore, and provides personalized, high-quality health checkup services.
Q: What is NEC's future plan for the expansion of the FonesVisuas service?
A: NEC intends to expand the sales of FonesVisuas overseas, with a focus on the APAC region.